Search Results - "Chatal, J.F."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Le cancer de prostate métastatique. Une cible : le PSMA – un traitement : la radioimmunothérapie by Rousseau, C., Le Thiec, M., Fleury, V., Rusu, D., Denis, A., Colombié, M., Kraeber-Bodéré, F., Chatal, J.F.

    “…Le cancer de la prostate métastatique n’est que sensible transitoirement à la chimiothérapie actuelle. La thérapie par des anticorps monoclonaux radiomarqués…”
    Get full text
    Journal Article
  2. 2

    Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer by Kraeber-Bodéré, F, Goldenberg, D M, Chatal, J F, Barbet, J

    Published in Current oncology (Toronto) (01-09-2009)
    “…Medullary thyroid carcinoma (mtc) is a rare cancer (less than 8% of all thyroid cancers) that occurs both as a familial and as a sporadic disease [...]…”
    Get full text
    Journal Article
  3. 3

    Radioimmunodetection of Medullary Thyroid Carcinoma Using Indium-111 Bivalent Hapten and Anti-CEA x Anti-DTPA-Indium Bispecific Antibody by Barbet, J, Peltier, P, Bardet, S, Vuillez, J.P, Bachelot, I, Denet, S, Olivier, P, Leccia, F, Corcuff, B, Huglo, D, Proye, C, Rouvier, E.P.Meyer, Chatal, J.F

    Published in The Journal of nuclear medicine (1978) (01-07-1998)
    “…Pretargeting labeled bivalent hapten with bispecific antibodies has proven feasible in the clinic, and our earlier results have suggested the technique may be…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Nuclear Medicine Applications for Neuroendocrine Tumors by Chatal, J.F., Le Bodic, M.F., Kraeber‐Bodéré, F., Rousseau, C., Resche, I.

    Published in World journal of surgery (01-11-2000)
    “…Sensitive, specific radiopharmaceuticals are available for scintigraphic diagnosis and internal radiotherapy of neuroendocrine tumors. 123I‐MIBG…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Lymphoscintigraphy in the Sentinel Lymph Node Technique for Breast Tumor: Value of Early and Late Images for the Learning Curve by Rousseau, C., Campion, L., Curtet, C., Classe, J.M., Dravet, F., Fiche, M., Sagan, C., Chatal, J.F., Resche, I.

    Published in Medical principles and practice (01-01-2003)
    “…As the performance of early (H+1 to H+4) and late (D1) lymphoscintigraphic images raises organizational problems in outpatient surgery for breast cancer, only…”
    Get full text
    Journal Article
  7. 7

    Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas by CHATAL, J.-F, SACCAVINI, J.-C, GESTIN, J.-F, THEDREZ, P, CURTET, C, KREMER, M, GUERREAU, D, NOLIBE, D, FUMOLEAU, P, GUILLARD, Y

    Published in Cancer research (Chicago, Ill.) (01-06-1989)
    “…The biodistribution of 111In-labeled monoclonal antibody (MAb) OC 125 was studied after i.p. injection in 28 patients who underwent surgery for ovarian…”
    Get full text
    Journal Article
  8. 8

    Cell death induced by a 131I-labeled monoclonal antibody in ovarian cancer multicell spheroids by Filippovich, I.V, Sorokina, N, Robillard, N, Faivre-Chauvet, A, Bardies, M, Chatal, J.F

    Published in Nuclear medicine and biology (01-07-1996)
    “…Treatment of OVCAR-3 spheroids with 131I-OC125 monoclonal antibody produced a decrease in spheroid volume and a concomitant rise in necrotic cell number. No…”
    Get full text
    Journal Article
  9. 9

    Evaluation of Indium-111-Labeled Antifibrin Monoclonal Antibody for the Diagnosis of Venous Thrombotic Disease by De Faucal, Philippe, Peltier, Patrick, Planchon, Bernard, Dupas, Benoit, Touze, Marie-Dominique, Baron, Denis, Scaible, Tom, Berger, Harvey J, Chatal, Jean-Francois

    Published in The Journal of nuclear medicine (1978) (01-05-1991)
    “…The potential advantage of using 111In-antifibrin (111In-AF) monoclonal antibody for the diagnosis of deep venous thrombosis (DVT) was studied in 44 patients…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance by Slinkin, M A, Curtet, C, Faivre-Chauvet, A, Sai-Maurel, C, Gestin, J F, Torchilin, V P, Chatal, J F

    Published in Nuclear medicine and biology (01-05-1993)
    “…F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody (mAb) were modified with three chain-terminal polylysine-based chelating polymers…”
    Get more information
    Journal Article
  12. 12

    Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma by THEDREZ, P, SACCAVINI, J.-C, NOLIBE, D, SIMOEN, J.-P, GUERREAU, D, GESTIN, J.-F, KREMER, M, CHATAL, J.-F

    Published in Cancer research (Chicago, Ill.) (01-06-1989)
    “…The purpose of this work was to study the biodistribution of 111In-labeled OC 125 monoclonal antibody (MAb) with known affinity for ovarian carcinomas in a…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Biodistribution of an anti-interleukin 2 receptor monoclonal antibody in rat recipients of a heart allograft, and its use as a rejection marker in gamma scintigraphy by Thedrez, P, Paineau, J, Jacques, Y, Chatal, J F, Pelegrin, A, Bouchaud, C, Soulillou, J P

    Published in Transplantation (01-09-1989)
    “…Anti-interleukin-2 receptor monoclonal antibodies have been shown to prevent allograft rejection. This paper reports on the biodistribution of a mouse MoAb…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Enzyme-linked immunosorbent assay to monitor colorectal carcinoma patients treated with a monoclonal antibody (17-1A) by Curtet, C, Maurel, C, Douillard, J Y, Le Mevel, B, Kremer, M, Sai, P, Chatal, J F

    Published in Journal of immunological methods (24-10-1985)
    “…An enzyme-linked immunosorbent assay (ELISA) was compared to a radioimmunoassay (RIA) for the detection and quantification of mouse monoclonal antibody MoAb…”
    Get more information
    Journal Article
  19. 19

    The joint Task Group on clinical utility of labelled antibodies of the Society of Nuclear Medicine Europa (SNME) and the European Nuclear Medicine Society (ENMS) by Buraggi, G, Britton, K E, Büll, U, Emrich, D, Fueger, G, Winkler, C G, Bishop-Delaloye, A, Chatal, J F, Dienstbier, Z, Ell, P J

    “…In September 1985 a task group on the clinical utility of labelled antibodies was founded by the Society of Nuclear Medicine - Europe. This document was…”
    Get more information
    Journal Article
  20. 20